Patent

Click here to view our Patent professionals

MBHB has experience on both sides of the patent - we are accomplished patent agents and deftly manage the patent prosecution process, while we also provide aggressive, goal-focused counsel in patent litigation matters.

Our attorneys have broad patent litigation experience, both enforcing patents and defending against infringement allegations. Our patent attorneys and patent agents are also highly adept in all aspects of patent procurement, including drafting applications and prosecuting them before the U.S. Patent and Trademark Office as well as in other countries. MBHB prosecutes interferences in the U.S. Patent and Trademark Office and assists in foreign patent oppositions. We negotiate patent licenses and help our clients establish and manage patent portfolios worldwide.

P: 312.913.2141
F: 312.913.0002
P: 312.913.3342
F: 312.913.0002
P: 312.913.2104
F: 312.913.0002
P: 312.935.2369
F: 312.913.0002
P: 312.913.2140
F: 312.913.0002
Senior Patent Agent
P: 312.913.3357
F: 312.913.0002
P: 312.913.2130
F: 312.913.0002
P: 312.913.3361
F: 312.913.0002
P: 312.913.2146
F: 312.913.0002
P: 312.913.3381
F: 312.913.0002
P: 312.913.2144
F: 312.913.0002
P: 312.913.3330
F: 312.913.0002
P: 312.913.2131
F: 312.913.0002
P: 312.913.3345
F: 312.913.0002
P: 312.913.3313
F: 312.913.0002
Associate
P: 312.913.3305
F: 312.913.0002
P: 312.913.3341
F: 312.913.0002
P: 312.913.3397
F: 312.913.0002
P: 312.913.2109
F: 312.913.0002
P: 312.913.2121
F: 312.913.0002
P: 360.379.6514
F: 312.913.2557
P: 312.913.2117
F: 312.913.0002
P: 312.913.3369
F: 312.913.0002
P: 312.913.2143
F: 312.913.0002
P: 312.913.3315
F: 312.913.0002
P: 312.913.3334
F: 312.913.0002
P: 312.913.2139
F: 312.913.0002
P: 312.913.3333
F: 312.913.0002
P: 312.913.3392
F: 312.913.0002
P: 312.913.3360
F: 312.913.0002
P: 312.913.3353
F: 312.913.0002
P: 312.913.2135
F: 312.913.0002
P: 312.913.3366
F: 312.913.0002
P: 312.913.2116
F: 312.913.0002
Associate
P: 312.913.2124
F: 312.913.0002
P: 312.913.2106
F: 312.913.0002
P: 312.913.3331
F: 312.913.0002
P: 312.935.2371
F: 312.913.0002
Patent Agent
P: 312.913.3319
F: 312.913.0002
P: 312.913.2123
F: 312.913.0002
P: 312.913.2122
F: 312.913.0002
P: 312.913.2137
F: 312.913.0002
P: 312.935.2372
F: 312.913.0002
P: 312.935.2355
F: 312.913.0002
P: 312.913.3304
F: 312.913.0002
Patent Agent
P: 312.913.3380
F: 312.913.0002
P: 312.913.3398
F: 312.913.0002
Associate
P: 312.913.2125
F: 312.913.0002
P: 312.913.3311
F: 312.913.0002
Associate
P: 312.913.2113
F: 312.913.0002
P: 312.913.3393
F: 312.913.0002
P: 312.913.3346
F: 312.913.0002
P: 312.913.3338
F: 312.913.0002
P: 312.913.2112
F: 312.913.0002
P: 312.913.2129
F: 312.913.0002
Patent Agent
P: 312.913.3358
F: 312.913.0002
P: 312.913.2101
F: 312.913.0002
P: 312.935.2359
F: 312.913.0002
Patent Agent
P: 312.913.2357
F: 312.913.0002
P: 312.913.3344
F: 312.913.0002
P: 312.913.2126
F: 312.913.0002
P: 312.913.3350
F: 312.913.0002
P: 312.913.3302
F: 312.913.0002
P: 312.935.2370
F: 312.913.0002
P: 312.913.2145
F: 312.913.0002
P: 312.913.3396
F: 312.913.0002
Technical Advisor
P: 312.913.3394
F: 312.913.0002
P: 312.913.2147
F: 312.913.0002
P: 312.913.3335
F: 312.913.0002
P: 312.913.3349
F: 312.913.0002
Associate
P: 312.913.2118
F: 312.913.0002
P: 312.935.2366
F: 312.913.0002
P: 312.913.3303
F: 312.913.0002
P: 312.913.3376
F: 312.913.0002
P: 312.913.3347
F: 312.913.0002
P: 312.913.3399
F: 312.913.0002
P: 312.913.2133
F: 312.913.0002
P: 312.913.3351
F: 312.913.0002
P: 312.913.3356
F: 312.913.0002
P: 312.913.2119
F: 312.913.0002
P: 312.913.2136
F: 312.913.0002
P: 312.935.2353
F: 312.913.0002
P: 312.913.3391
F: 312.913.0002
P: 312.913.3337
F: 312.913.0002
P: 312.913.3359
F: 312.913.0002
P: 312.913.0001
F: 312.913.0002
P: 312.913.3367
F: 312.913.0002
P: 312.913.3348
F: 312.913.0002
P: 312.935.2356
F: 312.913.0002
P: 312.913.3329
F: 312.913.0002
P: 312.913.3300
F: 312.913.0002
P: 312.935.2379
F: 312.913.0002
P: 312.913.2128
F: 312.913.0002
P: 312.913.3368
F: 312.913.0002
P: 312.913.2138
F: 312.913.0002
P: 312.913.3301
F: 312.913.0002
P: 312.913.2114
F: 312.913.0002
Partner
P: 312.913.3390
F: 312.913.0002
Associate
P: 312.913.2142
F: 312.913.0002
P: 312.913.2132
F: 312.913.0002

Upcoming Events

January 20, 2015
MBHB Attorneys Donald L. Zuhn, Jr., Ph.D., Kevin E. Noonan, Ph.D. and Michael S. Borella, Ph.D. Are the Featured Presenters

Past Event

November 20, 2014
MBHB Partners Alison Baldwin and Rory Shea Are the Featured Presenters
November 19-21, 2014
November 5-6, 2014
MBHB Partners Lisa Schoedel and James Suggs Are Featured Co-Presenters at this Management Forum-Sponsored Conference
October 21, 2014
MBHB Partner Patrick Gattari Is the Featured Presenter
October 20, 2014
MBHB Partner Lisa Schoedel Is the Featured Presenter at this IEEE-Sponsored Program

Publications

Fall 2014 (snippets)
When Congress created the Inter Partes Review (“IPR”) and Covered Business Method (“CBM”) review procedures for challenging the validity of an issued patent, it was intended for these processes to be quicker and more cost-effective than challenging patent validity in the district court system. One of the mechanisms Congress utilized for achieving these objectives was limiting the types of discovery allowed as part of the IPR and CBM processes. This was a lofty goal and pundits questioned whether this restricted scope of discovery could be maintained in practice. With the passage of two years under the IPR and CBM systems, a noticeable trend has emerged regarding how the Patent Trial and Appeal Board is accomplishing these Congressional objectives through its decisions on motions for additional discovery.
Fall 2014 (snippets)
Unlike patents and copyrights, trade secrets have historically been protected primarily under state law rather than federal law. That long history may soon change, as bills to create a federal cause of action for trade secret misappropriation are advancing through both houses of the U.S. Congress. These bills would allow trade secret owners to bring a federal civil action for trade secret misappropriation as long as the trade secret “is related to a product or service used in, or intended for use in, interstate or foreign commerce.” And, for the first time ever, the pending bills have the bipartisan support necessary for passage.
Fall 2014 (snippets)
The America Invents Act’s (“AIA’s”) overhaul of the U.S. Patent law system has significantly redefined what constitutes available prior art that can be used to reject patent applications or invalidate patents. In this article, we will discuss how the AIA expanded the definition of prior art, describe the AIA § 102 prior art exceptions, and suggest strategies that practitioners can consider in dealing with prior art and transitional applications.
November 17, 2014

Prior to filing a patent application at the United States Patent and Trademark Office (“USPTO”), an applicant seeking patent protection for an invention should consider conducting a prior art search. Also known as a patentability search, a prior art search involves discovering and examining art, such as issued patents, published patent applications, and other published documents, that can affect the potential to obtain a patent on the invention. More exhaustive prior art searches may also include discovering and examining any prior uses or prior sales of technology related to the invention.

Summer 2014 (snippets)
The CLS Bank case is the most recent of the Court’s patent eligibility decisions, and the Court unanimously affirmed the Federal Circuit's per curiam opinion (itself an effort to apply the Court’s patent eligibility jurisprudence regarding computer-based methods) that all of Alice’s claims were too abstract to meet the requirements of § 101. The claims at issue included method claims (directed, according to the Court, to methods for implementing an intermediated settlement that are well-known in the art), system claims involving implementation of the method using a general purpose computer, and computer readable-media claims for directing a general purpose computer to implement the method. None of the distinctions thought heretofore to matter between claims to methods, systems, and computer-readable media made any difference to the Court.
Summer 2014 (snippets)
In the seminal decision of Egyptian Goddess, Inc. v. Swisa, Inc., the Federal Circuit struck down one of the two tests commonly used for determining design patent infringement, the “point of novelty” test. Despite rejecting this test, the court incorporated the consideration of prior art into a slightly revised version of the "ordinary observer" test, the hypothetical "ordinary observer" now having familiarity with the prior art. This article will examine the application of this revised version of the "ordinary observer" test, and specifically the consideration of the “plainly dissimilar” analysis set forth by Egyptian Goddess.
Close
Generate a PDF of your page(s)
Clear
Close
Remove
Page has been queued
An error has occurred
Add
Added to queue
View
Confirm Delete All Message
No Items in Packet Message
To add a page, select Add. To view the package, select View.
false
http://www.mbhb.com/services/xpqServiceDetail.aspx?xpST=ServiceDetail&service=289&pdf=yes
a[href='javascript:packetBuilderSingleClick(document.title);']